Salivary Interleukins-6 and 8: Role in diagnosis of oral cancer
Not Applicable
- Conditions
- Health Condition 1: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx
- Registration Number
- CTRI/2024/01/061960
- Lead Sponsor
- AIIMS, Rajkot
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
case subjects (patients) with a comprehensive and thorough clinical examination and confirmation by a biopsy
Controls with no history of systemic illness
Exclusion Criteria
not willing to give written inform consent
cases with gingivitis
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways link IL-6 and IL-8 to oral cancer progression and premalignant lesion development?
How effective are salivary IL-6/IL-8 biomarkers compared to traditional diagnostic methods for oral squamous cell carcinoma?
Which patient subgroups with oral pre-malignant lesions show elevated IL-6 and IL-8 levels in saliva?
What are the limitations of using IL-6/IL-8 as non-invasive biomarkers for early oral cancer detection?
Are there existing therapies targeting IL-6/IL-8 signaling pathways in head and neck cancer treatment?